These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 26141032

  • 21. Urinary Kidney injury molecule-1 can predict delayed graft function in living donor renal allograft recipients.
    Yadav B, Prasad N, Agrawal V, Jaiswal A, Agrawal V, Rai M, Sharma R, Gupta A, Bhadauria D, Kaul A.
    Nephrology (Carlton); 2015 Nov; 20(11):801-6. PubMed ID: 25989460
    [Abstract] [Full Text] [Related]

  • 22. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH, Susskind B, Kerman D, Lam M, Gerolami K, Williams J, Kalish R, Campbell M, Katz S, Van Buren CT, Frazier H, Radovancevic B, Fife S, Kahan B.
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [Abstract] [Full Text] [Related]

  • 23. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
    Billing H, Sander A, Süsal C, Ovens J, Feneberg R, Höcker B, Vondrak K, Grenda R, Friman S, Milford DV, Lucan M, Opelz G, Tönshoff B.
    Transpl Int; 2013 Mar; 26(3):331-8. PubMed ID: 23279372
    [Abstract] [Full Text] [Related]

  • 24. Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients.
    Borelli SD, Ferreira E, Oliveira AM, Krishnaswamy S, Hiraki DD, Grumet FC.
    Hum Immunol; 1999 May; 60(5):430-4. PubMed ID: 10447402
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction.
    Domenico TD, Joelsons G, Montenegro RM, Manfro RC.
    Braz J Med Biol Res; 2017 Apr 03; 50(4):e5533. PubMed ID: 28380212
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA, Vaessen LM, Balk AH, Weimar W, Doxiadis II, Claas FH.
    Transpl Immunol; 2000 Mar 03; 8(1):57-64. PubMed ID: 10834611
    [Abstract] [Full Text] [Related]

  • 31. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
    Misra MK, Prakash S, Kapoor R, Pandey SK, Sharma RK, Agrawal S.
    Tissue Antigens; 2013 Nov 03; 82(5):317-26. PubMed ID: 24131018
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts.
    Kotanko P, Margreiter R, Pfaller W.
    Nephron; 2000 Mar 03; 84(3):228-35. PubMed ID: 10720893
    [Abstract] [Full Text] [Related]

  • 34. Urinary Calprotectin Differentiates Between Prerenal and Intrinsic Acute Renal Allograft Failure.
    Seibert FS, Rosenberger C, Mathia S, Arndt R, Arns W, Andrea H, Pagonas N, Bauer F, Zidek W, Westhoff TH.
    Transplantation; 2017 Feb 03; 101(2):387-394. PubMed ID: 26901081
    [Abstract] [Full Text] [Related]

  • 35. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
    Shi WW, Lin A, Xu DP, Bao WG, Zhang JG, Chen SY, Li J, Yan WH.
    Hum Immunol; 2011 Nov 03; 72(11):1068-73. PubMed ID: 21762747
    [Abstract] [Full Text] [Related]

  • 36. Human leukocyte antigen-G-14-base-pair-insertion/deletion polymorphism and graft survival in kidney transplant recipients.
    Hou W, Huang Z, Ji Z, Zhou J.
    Exp Clin Transplant; 2014 Apr 03; 12(2):89-94. PubMed ID: 24702138
    [Abstract] [Full Text] [Related]

  • 37. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.
    DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ.
    Hum Immunol; 1994 Jul 03; 40(3):191-201. PubMed ID: 7960963
    [Abstract] [Full Text] [Related]

  • 38. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L, Shi BY, Cai M, He XY, Xu XG, Han Y, Zhou WQ, Meng XY, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 26; 90(4):241-4. PubMed ID: 20356537
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M, Dahl M, Buus S, Djurisic S, Ohlsson J, Hviid TV.
    Tissue Antigens; 2014 Aug 26; 84(2):206-15. PubMed ID: 24785939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.